Evaluation of an Information Pamphlet for Postpartum Women That Had a Hypertensive Pregnancy
NCT ID: NCT02523781
Last Updated: 2021-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2015-06-30
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Educational Tools for Pregnant Women
NCT01858324
Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy
NCT03613714
Prediction of Preeclampsia and Other Pregnancy Complications Following Combined Iterative Screening
NCT03067298
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
NCT02147626
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
NCT05826925
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Then, women in the intervention group will receive the pamphlet. One month after, women in both groups will receive a questionnaire similar to the first one assessing knowledge about risks in the future, perception of cardiovascular risk, anxiety about that risk and satisfaction about information received or collected, including the pamphlet for the intervention group.
The pamphlet was validated by a multidisciplany team including patients, doctors, nurses, education specialists and communication specialists.
The questionnaire was also validated by the same multidisciplinary team. Section on knowledge and anxiety were remodeled from previously validated questionnaires Section on perception of cardiovascular risk was reproduced and translated with permission from its author.
Section on satisfaction was reproduced from the investigators' previous study where it was validated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
The control group does not receive the information pamphlet
No interventions assigned to this group
Intervention group
The intervention group receives the information pamphlet
information pamphlet
The intervention group receives the information pamphlet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
information pamphlet
The intervention group receives the information pamphlet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* followed at the CHUS obstetrical clinic for a 4 weeks to 18 months postpartum follow up
* had hypertension in her last pregnancy
Exclusion Criteria
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Sherbrooke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nadine Sauvé
Researcher of the Mother-Child axis of the CRCHUS
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sauvé Nadine, MD
Role: PRINCIPAL_INVESTIGATOR
Université de Sherbrooke
Anne-Marie côté, MD
Role: STUDY_CHAIR
Université de Sherbrooke
Annabelle Cumyn, MD
Role: STUDY_CHAIR
Université de Sherbrooke
Marie-Eve Roy-Lacroix, MD
Role: STUDY_CHAIR
Université de Sherbrooke
Myriam Champagne, MD
Role: STUDY_CHAIR
Université de Sherbrooke
Marie-Hélène Pesant, MD
Role: STUDY_CHAIR
Université de Sherbrooke
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hopitalier Universiatire de Sherbrooke
Sherbrooke, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-1099
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.